Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised
The Lancet Child & Adolescent Health . 7 ( 3 ) : 180-189
Journal article
see the publication